Anti-CD138-Targeted Interferon Is a Potent Therapeutic Against Multiple Myeloma

Multiple myeloma (MM), a plasma cell malignancy, is the second most prevalent hematologic malignancy in the US. Although much effort has been made trying to understand the etiology and the complexities of this disease with the hope of developing effective therapies, MM remains incurable at this time...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Interferon Cytokine Res
Main Authors: Yoo, Esther M., Trinh, Kham R., Tran, Danh, Vasuthasawat, Alex, Zhang, Juan, Hoang, Bao, Lichtenstein, Alan, Morrison, Sherie L.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2015
Assuntos:
Research Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4390003/
https://ncbi.nlm.nih.gov/pubmed/25353626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jir.2014.0125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados